| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |